ArticleExploration of targeted anti-tumor therapy2024

Predictive markers of response to immune checkpoint inhibitor rechallenge in metastatic non-small cell lung cancer.

Aram A Musaelyan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.